Kestra Medical Technologies (NASDAQ:KMTS) Earns Buy Rating from Analysts at Bank of America

Bank of America started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research report report published on Monday, Marketbeat.com reports. The firm issued a buy rating and a $30.00 price objective on the stock.

KMTS has been the topic of a number of other reports. The Goldman Sachs Group assumed coverage on Kestra Medical Technologies in a research report on Monday. They set a “neutral” rating and a $24.00 price target on the stock. Wells Fargo & Company began coverage on Kestra Medical Technologies in a research note on Monday. They issued an “overweight” rating and a $28.00 target price for the company. Wolfe Research assumed coverage on shares of Kestra Medical Technologies in a research report on Monday. They set an “outperform” rating and a $29.00 price target on the stock. Piper Sandler initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $27.00 price objective for the company. Finally, Stifel Nicolaus initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They set a “buy” rating and a $28.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Trading Up 4.6 %

Shares of Kestra Medical Technologies stock opened at $25.70 on Monday. Kestra Medical Technologies has a 1-year low of $20.00 and a 1-year high of $26.06.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.